Risks of Glaxo diabetes drug still unclear: FDA
63282
The potential heart risks of GlaxoSmithKline Plc's diabetes drug Avandia are still not clear, the head of the U.S. Food and Drug Administration told lawmakers who questioned the agency's oversight of the widely used pill on Wednesday.
140789
In the month after a surprising analysis revealed possible heart risks from the blockbuster diabetes drug Avandia, reports of side effects to federal regulators tripled.
249661
About two-thirds of Food and Drug Administration scientists are less than fully confident in the agency's monitoring of the safety of prescription drugs now being sold.
655501
GlaxoSmithKline Plc  faces a U.S. investor lawsuit claiming that Europe's biggest drugmaker misled shareholders about the safety of diabetes drug Avandia.
375225
U.S. health regulators warned on Monday of heart risks connected to over-the-counter painkiller naproxen, creating additional confusion over the safety of similar drugs after recent warnings for two other painkillers.
384589
The widow and son of a Texas man who was taking a GlaxoSmithKline Plc diabetes drug at the time of his fatal heart attack claims the drugmaker failed to warn about the drug's risks, according to a lawsuit.
667330
Business & money: Europe's largest drugmaker blames safety concerns over its Avandia diabetes pill
114045
The diabetes drugs Actos and Avandia raise the risk of heart failure but do not increase the risk of heart-related death, U.S. researchers said on Thursday, confirming earlier findings.
154341
A leading diabetes doctor sent the Food and Drug Administration a letter seven years ago that warned of the heart risks of the drug Avandia.
549121
A U.S. Food and Drug Administration preliminary analysis found a level of heart-attack risk with GlaxoSmithKline Plc'sdiabetes drug Avandia similar to what was reported in a study earlier this week, the agency confirmed on Friday.
443819
U.S. regulators have asked for more data  on Novartis AG's  diabetes drug Galvus, possibly  delaying approval of the potential blockbuster by a year, which  dented its shares while boosting its main rival's.
508415
An early analysis from an ongoing study of GlaxoSmithKline Plc's Avandia was unable to show whether there was any increase in heart attacks among patients, but several experts said the evidence still suggested the popular diabetes drug raised the risk of heart attack.
411023
QUESTION: I&#39;ve been trying to avoid artificial sweeteners, so I&#39;ve been buying regular soft drinks. Now I hear that they can lead to diabetes.
301674
Dec. 9, 2004 - New documents uncovered by ABC News suggest GlaxoSmithKline, the maker of the popular antidepressant Paxil, failed to disclose important information about the possibility of an increased risk
188930
GlaxoSmithKline's diabetes drug Avandia was not to blame for heart deaths in a trial to see if treating diabetes would reduce heart disease, U.S. government-funded researchers said on Wednesday.
203886
The maker of the controversial diabetes pill Avandia pointed to early results of its own study Tuesday, saying they offered reassuring evidence the drug doesn't raise heart risks. However, outside experts called the results inconclusive at best and a sign of greater risk at worst.
450325
U.S. health officials and drugmaker GlaxoSmithKline Plc are likely to face tough questioning from lawmakers on Wednesday over their handling of data suggesting a heart risk with the widely used diabetes pill Avandia.